Omi/HtrA2 and XIAP are components of platelet apoptosis signalling

Thrombosis and Haemostasis

Volumn 109, Issue 3, 2013, Pages 532-539

  Winkler, Jeannine ^a,b   Rand, Margaret L ^c   Schmugge, Markus ^a   Speer, Oliver ^a,b  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Apoptosis; Caspase 3; Omi HtrA2, XIAP; Platelets

Indexed keywords

4 [4 (4' CHLORO 2 BIPHENYLYLMETHYL) 1 PIPERAZINYL] N [4 [3 DIMETHYLAMINO 1 (PHENYLTHIOMETHYL) PROPYLAMINO] 3 NITROBENZENESULFONYL] BENZAMIDE; 5-[5-(2-NITROPHENYL) FURFURYLIODINE]-1,3-DIPHENYL-2-THIOBARBITURIC ACID; ADENOSINE DIPHOSPHATE; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; ARACHIDONIC ACID; CALCIMYCIN; CASPASE 3; CASPASE 7; CASPASE 9; CD63 ANTIGEN; COLLAGEN; CYTOCHROME C; MISCELLANEOUS DRUGS AND AGENTS; PADGEM PROTEIN; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL XL; PROTEIN BID; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; SERINE PROTEINASE OMI; THROMBIN; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTE AGGREGATION; WESTERN BLOTTING;

APOPTOSIS; BIPHENYL COMPOUNDS; BLOOD PLATELETS; CALCIMYCIN; CALCIUM; CASPASE 3; CASPASE 9; COLLAGEN; CYTOCHROMES C; CYTOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; HUMANS; IONOPHORES; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIAL PROTEINS; NITROPHENOLS; PIPERAZINES; SERINE ENDOPEPTIDASES; SIGNAL TRANSDUCTION; SULFONAMIDES; THROMBIN; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 84874771151     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH12-06-0404     Document Type: Article

References (35)

1. Hengartner MO. The biochemistry of apoptosis. Nature 2000; 407: 770-776.
2. Landes T, Martinou JC. Mitochondrial outer membrane permeabilisation during apoptosis: the role of mitochondrial fission. Biochim Biophys Acta 2011; 1813: 540-545.
3. Rasola A, Bernardi P. Mitochondrial permeability transition in Ca(2+)-dependent apoptosis and necrosis. Cell Calcium 2011; 50: 222-233.
4. Chai J, Shiozaki E, Srinivasula SM, et al. Structural basis of caspase-7 inhibition by XIAP. Cell 2001; 104: 769-780.
5. Martins LM, Iaccarino I, Tenev T, et al. The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif. J Biol Chem 2002; 277: 439-444.
6. van Loo G, van Gurp M, Depuydt B, et al. The serine protease Omi/HtrA2 is released from mitochondria during apoptosis. Omi interacts with caspase-inhibitor XIAP and induces enhanced caspase activity. Cell Death Differ 2002; 9: 20-26.
7. Hegde R, Srinivasula SM, Zhang Z, et al. Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis proteincaspase interaction. J Biol Chem 2002; 277: 432-438.
8. Srinivasula SM, Datta P, Fan XJ, et al. Molecular determinants of the caspasepromoting activity of Smac/DIABLO and its role in the death receptor pathway. J Biol Chem 2000; 275: 36152-36157.
9. Kuninaka S, Nomura M, Hirota T, et al. The tumor suppressor WARTS activates the Omi / HtrA2-dependent pathway of cell death. Oncogene 2005; 24: 5287-5298.
10. Yang QH, Church-Hajduk R, Ren J, et al. Omi/HtrA2 catalytic cleavage of inhibitor of apoptosis (IAP) irreversibly inactivates IAPs and facilitates caspase activity in apoptosis. Genes Dev 2003; 17: 1487-1496.
11. Cilenti L, Lee Y, Hess S, et al. Characterisation of a novel and specific inhibitor for the pro-apoptotic protease Omi/HtrA2. J Biol Chem 2003; 278: 11489-11494.
12. Cilenti L, Kyriazis GA, Soundarapandian MM, et al. Omi/HtrA2 protease mediates cisplatin-induced cell death in renal cells. Am J Physiol Renal Physiol 2005; 288: F371-379.
13. Blink E, Maianski NA, Alnemri ES, et al. Intramitochondrial serine protease activity of Omi/HtrA2 is required for caspase-independent cell death of human neutrophils. Cell Death Differ 2004; 11: 937-939.
14. Srinivasula SM, Hegde R, Saleh A, et al. A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis. Nature 2001; 410: 112-116.
15. Wu G, Chai J, Suber TL, et al. Structural basis of IAP recognition by Smac/ DIABLO. Nature 2000; 408: 1008-1012.
16. Leytin V. Apoptosis in the anucleate platelet. Blood Rev 2012; 26: 51-63.
17. Lopez JJ, Salido GM, Pariente JA, et al. Thrombin induces activation and translocation of Bid, Bax and Bak to the mitochondria in human platelets. J Thromb Haemost 2008; 6: 1780-1788.
18. Mason KD, Carpinelli MR, Fletcher JI, et al. Programmed anuclear cell death delimits platelet life span. Cell 2007; 128: 1173-1186.
19. Schoenwaelder SM, Yuan Y, Josefsson EC, et al. Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function. Blood 2009; 114: 663-666.
20. Lopez JJ, Salido GM, Gomez-Arteta E, et al. Thrombin induces apoptotic events through the generation of reactive oxygen species in human platelets. J Thromb Haemost 2007; 5: 1283-1291.
21. Vogler M, Hamali HA, Sun XM, et al. BCL2/BCL-XL inhibition induces apoptosis, disrupts cellular calcium homeostasis, and prevents platelet activation. Blood 2011; 117: 7145-7154.
22. Wolf BB, Goldstein JC, Stennicke HR, et al. Calpain functions in a caspase-independent manner to promote apoptosis-like events during platelet activation. Blood 1999; 94: 1683-1692.
23. Mutlu A, Gyulkhandanyan AV, Freedman J, et al. Activation of caspases-9,-3 and-8 in human platelets triggered by BH3-only mimetic ABT-737 and calcium ionophore A23187: caspase-8 is activated via bypass of the death receptors. Br J Haematol 2012; Epub ahead of print.
24. Shcherbina A, Remold-O'Donnell E. Role of caspase in a subset of human platelet activation responses. Blood 1999; 93: 4222-4231.
25. Winkler J, Kroiss S, Rand ML, et al. Platelet apoptosis in paediatric immune thrombocytopenia is ameliorated by intravenous immunoglobulin. Br J Haematol 2012; 156: 508-515.
26. Song S, Crow AR, Freedman J, et al. Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIG. Blood 2003; 101: 3708-3713.
27. Cookson P, Sutherland J, Turner C, et al. Platelet apoptosis and activation in platelet concentrates stored for up to 12 days in plasma or additive solution. Transfus Med 2010; 20: 392-402.
28. Leung R, Gwozdz AM, Wang H, et al. Persistence of procoagulant surface expression on activated human platelets: involvement of apoptosis and aminophospholipid translocase activity. J Thromb Haemost 2007; 5: 560-570.
29. Schmugge M, Rand ML, Bang KW, et al. The relationship of von Willebrand factor binding to activated platelets from healthy neonates and adults. Pediatr Res 2003; 54: 474-479.
30. Plenchette S, Moutet M, Benguella M, et al. Early increase in DcR2 expression and late activation of caspases in the platelet storage lesion. Leukemia 2001; 15: 1572-1581.
31. White MJ, Schoenwaelder SM, Josefsson EC, et al. Caspase-9 mediates the apoptotic death of megakaryocytes and platelets, but is dispensable for their generation and function. Blood 2012; 119: 4283-4290.
32. Schoenwaelder SM, Jarman KE, Gardiner EE, et al. Bcl-xL-inhibitory BH3 mimetics can induce a transient thrombocytopathy that undermines the hemostatic function of platelets. Blood 2011; 118: 1663-1674.
33. Leytin V, Mykhaylov S, Starkey AF, et al. Intravenous immunoglobulin inhibits anti-glycoprotein IIb-induced platelet apoptosis in a murine model of immune thrombocytopenia. Br J Haematol 2006; 133: 78-82.
34. Leytin V, Allen DJ, Mykhaylov S, et al. Thrombin-triggered platelet apoptosis. J Thromb Haemost 2006; 4: 2656-2663.
35. Vande Walle L, Van Damme P, Lamkanfi M, et al. Proteome-wide Identification of HtrA2/Omi Substrates. J Proteome Res 2007; 6: 1006-1015.